Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,014Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Novartis Pharma Schweizerhalle AG

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for 1492952-76-7 / Asciminib API manufacturers, exporters & distributors?

Asciminib manufacturers, exporters & distributors 1

35

PharmaCompass offers a list of Asciminib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Asciminib manufacturer or Asciminib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Asciminib manufacturer or Asciminib supplier.

PharmaCompass also assists you with knowing the Asciminib API Price utilized in the formulation of products. Asciminib API Price is not always fixed or binding as the Asciminib Price is obtained through a variety of data sources. The Asciminib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Asciminib

Synonyms

Abl-001, 1492952-76-7, Abl001, Asciminib free base, Abl001-nx, Nvp-abl001

Cas Number

1492952-76-7

Unique Ingredient Identifier (UNII)

L1F3R18W77

About Asciminib

Asciminib is an orally bioavailable, allosteric Bcr-Abl1 tyrosine kinase inhibitor, with antineoplastic activity. Upon administration, asciminib targets and binds to the myristoyl pocket of the Bcr-Abl1 fusion protein at a location that is distinct from the ATP-binding domain, thereby inhibiting the activity of both wild-type Bcr-Abl and certain mutation forms, including the T315I mutation. This binding results in the inhibition of Bcr-Abl1-mediated proliferation and enhanced apoptosis of Philadelphia chromosome-positive (Ph+) hematological malignancies. The Bcr-Abl1 fusion protein tyrosine kinase is an abnormal enzyme produced by leukemia cells that contain the Philadelphia chromosome.

asciminib hydrochloride Manufacturers

A asciminib hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of asciminib hydrochloride, including repackagers and relabelers. The FDA regulates asciminib hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. asciminib hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of asciminib hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

asciminib hydrochloride Suppliers

A asciminib hydrochloride supplier is an individual or a company that provides asciminib hydrochloride active pharmaceutical ingredient (API) or asciminib hydrochloride finished formulations upon request. The asciminib hydrochloride suppliers may include asciminib hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of asciminib hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

asciminib hydrochloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing asciminib hydrochloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for asciminib hydrochloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture asciminib hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain asciminib hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a asciminib hydrochloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of asciminib hydrochloride suppliers with NDC on PharmaCompass.

asciminib hydrochloride Manufacturers | Traders | Suppliers

asciminib hydrochloride Manufacturers, Traders, Suppliers 1
66

We have 1 companies offering asciminib hydrochloride

Get in contact with the supplier of your choice:

  1. Novartis Pharmaceuticals Corporation
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.